STAAR Surgical Co. Form 8-K Summary
Business Context and Reporting Period
STAAR Surgical Co. (STAA) filed this Current Report on February 11, 2025, to announce financial results for the quarter and fiscal year ended December 27, 2024. The filing incorporates a press release and a slide presentation detailing these results and the company's outlook for fiscal year 2025.
Key Financial Metrics
The provided text serves as a cover document referencing the financial results but does not contain specific numerical data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this filing text.
Material Changes
Specific material changes versus the prior comparable period are not detailed in this document. The filing directs investors to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Management Commentary
- Conference Call: Management, including the CEO and CFO, held a conference call on February 11, 2025, to discuss results and the fiscal year 2025 outlook.
- Exhibits: The press release (Exhibit 99.1) and slide presentation (Exhibit 99.2) contain the detailed outlook and commentary.
- Legal Disclaimer: The information in Items 2.02 and 7.01 is furnished and not deemed "filed" under Section 18 of the Exchange Act, nor is it incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and EPS figures for the quarter and year ended December 27, 2024.
- Examine Exhibit 99.2 (Slide Presentation) for detailed fiscal year 2025 guidance and strategic updates.
- Verify the transcript of the February 11, 2025, conference call for management's qualitative assessment of market conditions and risks.
- Confirm that the financial data in the press release aligns with the company's previously filed 10-K or 10-Q reports.